Rubicon Research Company Description

Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally.

Its primary proprietary technologies for drug delivery comprising RubiSRL for the formulation of sustained release liquids using a combination of ion exchange and membrane diffusion controlled-release technologies; and RubiReten, a gastro-retentive system for drugs with poor solubility and a limited window of absorption.

The company develops products in the areas of analgesics/pain management, hypokalemia, gastrointestinal, cardiovascular, skeletal muscle relaxants, metabolic, central nervous system, nicotine replacement therapy, and immunosuppressant.

The company was incorporated in 1999 and is based in Mumbai, India.

Rubicon Research Limited

Country	India
Founded	1999
Industry	Pharmaceutical Preparations
Employees	903
CEO	Parag Sancheti

Contact Details

Address: MedOne House Mumbai, Maharashtra 400604 India
Phone	91 22 6141 4000
Website	rubicon.co.in

Stock Details

Ticker Symbol	RUBICON
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
SIC Code	2834

Key Executives

Name	Position
Parag Sancheti	Chief Executive Officer
Nitin Jajodia	Chief Financial Officer
Sumant Pilgaonkar	Chief Operating Officer